WallStSmart

NVIDIA Corporation (NVDA)vsWellchange Holdings Company Limited (WCT)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

NVIDIA Corporation generates 8829193% more annual revenue ($215.94B vs $2.45M). NVDA leads profitability with a 55.6% profit margin vs -154.5%. NVDA earns a higher WallStSmart Score of 79/100 (B+).

NVDA

Strong Buy

79

out of 100

Grade: B+

Growth: 10.0Profit: 10.0Value: 5.7Quality: 8.5
Piotroski: 3/9Altman Z: 6.75

WCT

Avoid

27

out of 100

Grade: F

Growth: 6.0Profit: 2.0Value: 5.0Quality: 6.5
Piotroski: 3/9Altman Z: 2.03

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

NVDA6 strengths · Avg: 10.0/10
Market CapQuality
$5.09T10/10

Mega-cap, among the largest globally

Return on EquityProfitability
101.5%10/10

Every $100 of equity generates 102 in profit

Profit MarginProfitability
55.6%10/10

Keeps 56 of every $100 in revenue as profit

Operating MarginProfitability
65.0%10/10

Strong operational efficiency at 65.0%

Revenue GrowthGrowth
73.2%10/10

Revenue surging 73.2% year-over-year

EPS GrowthGrowth
95.6%10/10

Earnings expanding 95.6% YoY

WCT2 strengths · Avg: 9.5/10
Price/BookValuation
0.2x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.129/10

Conservative balance sheet, low leverage

Areas to Watch

NVDA3 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

P/E RatioValuation
42.7x2/10

Premium valuation, high expectations priced in

Price/BookValuation
30.8x2/10

Trading at 30.8x book value

WCT4 concerns · Avg: 2.5/10
Market CapQuality
$5.83M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-51.3%2/10

ROE of -51.3% — below average capital efficiency

EPS GrowthGrowth
-3.1%2/10

Earnings declined 3.1%

Comparative Analysis Report

WallStSmart Research

Bull Case : NVDA

The strongest argument for NVDA centers on Market Cap, Return on Equity, Profit Margin. Profitability is solid with margins at 55.6% and operating margin at 65.0%. Revenue growth of 73.2% demonstrates continued momentum.

Bull Case : WCT

The strongest argument for WCT centers on Price/Book, Debt/Equity. Revenue growth of 12.9% demonstrates continued momentum.

Bear Case : NVDA

The primary concerns for NVDA are Piotroski F-Score, P/E Ratio, Price/Book. A P/E of 42.7x leaves little room for execution misses.

Bear Case : WCT

The primary concerns for WCT are Market Cap, Piotroski F-Score, Return on Equity.

Key Dynamics to Monitor

NVDA profiles as a growth stock while WCT is a turnaround play — different risk/reward profiles.

NVDA is growing revenue faster at 73.2% — sustainability is the question.

NVDA generates stronger free cash flow (34.9B), providing more financial flexibility.

Monitor SEMICONDUCTORS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

NVDA scores higher overall (79/100 vs 27/100), backed by strong 55.6% margins and 73.2% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

NVIDIA Corporation

TECHNOLOGY · SEMICONDUCTORS · USA

Nvidia Corporation is an American multinational technology company incorporated in Delaware and based in Santa Clara, California. It designs graphics processing units (GPUs) for the gaming and professional markets, as well as system on a chip units (SoCs) for the mobile computing and automotive market.

Visit Website →

Wellchange Holdings Company Limited

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Wellchange Holdings Company Limited (WCT) operates at the forefront of the healthcare and wellness industry, delivering innovative solutions aimed at improving consumer health and overall lifestyle. By leveraging advanced technology and adhering to sustainable practices, WCT offers a comprehensive portfolio of products and services that prioritize well-being. The company's robust focus on research and development, coupled with strategic partnerships, uniquely positions it to capitalize on the increasing global demand for health-focused solutions. As a result, WCT presents a compelling investment opportunity for institutional investors seeking to gain exposure to a rapidly expanding market.

Visit Website →

Want to dig deeper into these stocks?